Saturna Capital Corp Buys 12,582 Shares of Corteva, Inc. $CTVA

Saturna Capital Corp boosted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 49.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 38,135 shares of the company’s stock after purchasing an additional 12,582 shares during the period. Saturna Capital Corp’s holdings in Corteva were worth $2,556,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. JPL Wealth Management LLC bought a new stake in shares of Corteva during the 3rd quarter worth approximately $25,000. Redmont Wealth Advisors LLC acquired a new position in Corteva during the third quarter worth $29,000. Jackson Grant Investment Advisers Inc. raised its position in Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares in the last quarter. Basepoint Wealth LLC acquired a new stake in Corteva in the fourth quarter valued at $30,000. Finally, KERR FINANCIAL PLANNING Corp acquired a new stake in Corteva in the third quarter valued at $33,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Down 0.6%

CTVA stock opened at $74.59 on Thursday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. The stock has a market capitalization of $49.89 billion, a price-to-earnings ratio of 43.88, a PEG ratio of 2.29 and a beta of 0.57. The business’s fifty day moving average price is $80.72 and its two-hundred day moving average price is $75.24.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the company posted $1.13 earnings per share. Corteva’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Ratings Changes

Several research firms have recently weighed in on CTVA. The Goldman Sachs Group boosted their price objective on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Citigroup boosted their price target on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Royal Bank Of Canada upped their price objective on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Finally, BNP Paribas Exane raised their price objective on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $88.48.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.